vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2021-2-147-157vtio-1375Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSПатогенетические механизмы, эпидемиология и классификация острого повреждения почек у реципиентов сердечного трансплантатаPathogenetic mechanisms, epidemiology and classification of acute kidney injury in heart transplant recipientsПозЯ. Л.PozI. L.

Поз Яков Львович

123182, Москва, ул. Щукинская, д. 1

Iakov I. Poz

1, Shchukinskaya str., Moscow, 123182

dr.poz@list.ruСтроковА. Г.StrokovA. G.

Москва

Moscow

ПопцовВ. Н.PoptsovV. N.

Москва

Moscow

ШевченкоА. О.ShevchenkoA. O.

Москва

Moscow

ГотьеС. В.GautierS. V.

Москва

Moscow

ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial OrgansRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский университет)РоссияShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский университет); ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University; Pirogov Medical UniversityRussian Federation202112072021232147157Copyright © Поз Я.Л., Строков А.Г., Попцов В.Н., Шевченко А.О., Готье С.В., 20212021Поз Я.Л., Строков А.Г., Попцов В.Н., Шевченко А.О., Готье С.В.Poz I.L., Strokov A.G., Poptsov V.N., Shevchenko A.O., Gautier S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1375

Повреждение почек у реципиентов сердечного трансплантата имеет сложную природу и несет в себе черты всех типов нарушения кардиоренального взаимодействия. Предшествующая трансплантации почечная дисфункция, острое повреждение почек в периоперационном периоде, а также факторы, связанные с трансплантатом и иммуносупрессией, определяют распространенность и тяжесть патологии почек в этой группе больных. В данном обзоре рассмотрены патофизиология нарушения функции почек при сердечной недостаточности, эпидемиология и классификации острого повреждения почек.

Kidney injury in heart transplant recipients is of a complex nature and bears the features of all types of cardiorenal interaction impairment. Pre-transplant renal dysfunction, perioperative acute kidney injury, as well as factors associated with graft and immunosuppression, determine the prevalence and severity of kidney pathology in this group of patients. This review examines the pathophysiology of kidney dysfunction in heart failure, the epidemiology, and criteria for acute kidney injury.

кардиоренальный синдромтрансплантация сердцаэпидемиологияклассификация острого повреждения почекcardiorenal syndromeheart transplantationepidemiologycriteria for acute kidney injuryReferencesDasta JF, Kane-Gill S. Review of the Literature on the Costs Associated With Acute Kidney Injury. J Pharm Pract. 2019 Jun; 32 (3): 292–302. doi: 10.1177/0897190019852556.Dasta JF, Kane-Gill S. Review of the Literature on the Costs Associated With Acute Kidney Injury. J Pharm Pract. 2019 Jun; 32 (3): 292–302. doi: 10.1177/0897190019852556.Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34 (5): 957–962. doi: 10.1007/s00134-008-1017-8.Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34 (5): 957–962. doi: 10.1007/s00134-008-1017-8.Ronco C, Bellasi A, Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25 (5): 382–390. doi: 10.1053/j.ackd.2018.08.004.Ronco C, Bellasi A, Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25 (5): 382–390. doi: 10.1053/j.ackd.2018.08.004.Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007; 13: 422–430. doi: 10.1016/j.cardfail.2007.03.011.Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007; 13: 422–430. doi: 10.1016/j.cardfail.2007.03.011.Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009; 53: 582–588. doi: 10.1016/j.jacc.2008.08.080.Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009; 53: 582–588. doi: 10.1016/j.jacc.2008.08.080.Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail. 2010; 12: 974–982. doi: 10.1093/eurjhf/hfq118.Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail. 2010; 12: 974–982. doi: 10.1093/eurjhf/hfq118.Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51: 1268–1274. doi: 10.1016/j.jacc.2007.08.072.Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51: 1268–1274. doi: 10.1016/j.jacc.2007.08.072.Hanberg JS, Sury K, Wilson FP, Brisco MA, Ahmad T, Ter Maaten JM et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016; 67 (19): 2199–2208. doi: 10.1016/j.jacc.2016.02.058.Hanberg JS, Sury K, Wilson FP, Brisco MA, Ahmad T, Ter Maaten JM et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016; 67 (19): 2199–2208. doi: 10.1016/j.jacc.2016.02.058.Guglin M, Rivero A, Matar F, Garcia M. Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol. 2011; 34: 113–116. doi: 10.1002/clc.20831.Guglin M, Rivero A, Matar F, Garcia M. Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol. 2011; 34: 113–116. doi: 10.1002/clc.20831.Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail. 2008; 14: 824–830.Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail. 2008; 14: 824–830.Priebe HJ, Heimann JC, Hedley-Whyte J. Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac output in dogs. Circ Res. 1980; 47: 883–890. doi: 10.1161/01.res.47.6.883.Priebe HJ, Heimann JC, Hedley-Whyte J. Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac output in dogs. Circ Res. 1980; 47: 883–890. doi: 10.1161/01.res.47.6.883.Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007; 9: 872–878. doi: 10.1016/j.ejheart.2007.05.010.Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007; 9: 872–878. doi: 10.1016/j.ejheart.2007.05.010.Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T et al. Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail. 2011; 13: 432–439. doi: 10.1093/eurjhf/hfq195.Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T et al. Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail. 2011; 13: 432–439. doi: 10.1093/eurjhf/hfq195.Blankstein R, Bakris GL. Renal hemodynamic changes in heart failure. Heart Fail Clin. 2008; 4 (4): 411–423. doi: 10.1016/j.hfc.2008.03.006.Blankstein R, Bakris GL. Renal hemodynamic changes in heart failure. Heart Fail Clin. 2008; 4 (4): 411–423. doi: 10.1016/j.hfc.2008.03.006.Sambandam KK. Effective use of loop diuretics in heart failure exacerbation: a nephrologist’s view. Am J Med Sci. 2014; 347: 139–145. doi: 10.1097/MAJ.0b013e31828a2962.Sambandam KK. Effective use of loop diuretics in heart failure exacerbation: a nephrologist’s view. Am J Med Sci. 2014; 347: 139–145. doi: 10.1097/MAJ.0b013e31828a2962.Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart, don’t mind the kidney. Eur Heart J. 2011; 32: 2476–2478. doi: 10.1093/eurheartj/ehr242.Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart, don’t mind the kidney. Eur Heart J. 2011; 32: 2476–2478. doi: 10.1093/eurheartj/ehr242.Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006; 47: 1–8. doi: 10.1016/j.jacc.2005.07.067.Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006; 47: 1–8. doi: 10.1016/j.jacc.2005.07.067.Guazzi M, Gatto P, Giusti G, Pizzamiglio F, Previtali I, Vignati C, Arena R. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction. Int J Cardiol. 2013; 169: 379– 384. doi: 10.1016/j.ijcard.2013.09.014.Guazzi M, Gatto P, Giusti G, Pizzamiglio F, Previtali I, Vignati C, Arena R. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction. Int J Cardiol. 2013; 169: 379– 384. doi: 10.1016/j.ijcard.2013.09.014.Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF. Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. J Trauma. 2000; 49: 621–626; discussion 626–627. doi: 10.1097/00005373-200010000-00008.Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF. Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension. J Trauma. 2000; 49: 621–626; discussion 626–627. doi: 10.1097/00005373-200010000-00008.Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intraabdominal pressure increases plasma renin activity and aldosterone levels. J Trauma. 1997; 42: 997–1004; discussion 1004–1005. doi: 10.1097/00005373-199706000-00002.Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intraabdominal pressure increases plasma renin activity and aldosterone levels. J Trauma. 1997; 42: 997–1004; discussion 1004–1005. doi: 10.1097/00005373-199706000-00002.Harman PK, Kron IL, McLachlan HD, Freedlender AE, Nolan SP. Elevated intra-abdominal pressure and renal function. Ann Surg. 1982 Nov; 196 (5): 594–597. doi: 10.1097/00000658-198211000-00015.Harman PK, Kron IL, McLachlan HD, Freedlender AE, Nolan SP. Elevated intra-abdominal pressure and renal function. Ann Surg. 1982 Nov; 196 (5): 594–597. doi: 10.1097/00000658-198211000-00015.Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WHW, Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62: 485–495. doi: 10.1016/j.jacc.2013.04.070.Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WHW, Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62: 485–495. doi: 10.1016/j.jacc.2013.04.070.Sandek A, Rauchhaus M, Anker SD, von Haehling S. The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care. 2008; 11: 632–639. doi: 10.1097/MCO.0b013e32830a4c6e.Sandek A, Rauchhaus M, Anker SD, von Haehling S. The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care. 2008; 11: 632–639. doi: 10.1097/MCO.0b013e32830a4c6e.Sandek A, Anker SD, von Haehling S. The gut and intestinal bacteria in chronic heart failure. Curr Drug Metab. 2009; 10 (1): 22–28. doi: 10.2174/138920009787048374.Sandek A, Anker SD, von Haehling S. The gut and intestinal bacteria in chronic heart failure. Curr Drug Metab. 2009; 10 (1): 22–28. doi: 10.2174/138920009787048374.Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail. 2012; 18: 930–938. doi: 10.1016/j.cardfail.2012.10.010.Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail. 2012; 18: 930–938. doi: 10.1016/j.cardfail.2012.10.010.Colombo PC, Onat D, Harxhi A, Demmer RT, Hayashi Y, Jelic S et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J. 2014; 35: 448–454. doi: 10.1093/eurheartj/eht456.Colombo PC, Onat D, Harxhi A, Demmer RT, Hayashi Y, Jelic S et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J. 2014; 35: 448–454. doi: 10.1093/eurheartj/eht456.Iwata K, Matsuno K, Murata A, Zhu K, Fukui H, Ikuta K et al. Up-regulation of NOX1/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis. Free Radic Biol Med. 2018; 120: 277–288. doi.org/10.1016/j.freeradbiomed.2018.03.053.Iwata K, Matsuno K, Murata A, Zhu K, Fukui H, Ikuta K et al. Up-regulation of NOX1/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis. Free Radic Biol Med. 2018; 120: 277–288. doi.org/10.1016/j.freeradbiomed.2018.03.053.Afsar B, Ortiz A, Covic A, Solak Y, Goldsmith D, Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016; 9 (1): 39–47. doi: 10.1093/ckj/sfv124.Afsar B, Ortiz A, Covic A, Solak Y, Goldsmith D, Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016; 9 (1): 39–47. doi: 10.1093/ckj/sfv124.Rockey DC, Bell PD, Hill JA. Fibrosis: a common pathway to organ injury and failure. N Engl J Med. 2015; 372: 1138–1149. doi: 10.1056/NEJMra1300575.Rockey DC, Bell PD, Hill JA. Fibrosis: a common pathway to organ injury and failure. N Engl J Med. 2015; 372: 1138–1149. doi: 10.1056/NEJMra1300575.Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016; 118: 1021–1040. doi: 10.1161/CIRCRESAHA.115.306565.Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016; 118: 1021–1040. doi: 10.1161/CIRCRESAHA.115.306565.Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sádaba JR et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail. 2015; 3: 59–67. doi: 10.1016/j.jchf.2014.08.002.Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sádaba JR et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail. 2015; 3: 59–67. doi: 10.1016/j.jchf.2014.08.002.Lattenist L, Lechner SM, Messaoudi S, Le Mercier A, El Moghrabi S, Prince S et al. Nonsteroidal mineralocorticoid receptor antagonist finerenone protects against acute kidney injury-mediated chronic kidney disease: role of oxidative stress. Hypertension. 2017; 69: 870–878. doi: 10.1161/HYPERTENSIONAHA.116.08526.Lattenist L, Lechner SM, Messaoudi S, Le Mercier A, El Moghrabi S, Prince S et al. Nonsteroidal mineralocorticoid receptor antagonist finerenone protects against acute kidney injury-mediated chronic kidney disease: role of oxidative stress. Hypertension. 2017; 69: 870–878. doi: 10.1161/HYPERTENSIONAHA.116.08526.Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303: 959–966. doi: 10.1001/jama.2010.237.Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303: 959–966. doi: 10.1001/jama.2010.237.Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O et al. Long-term risks for kidney donors. Kidney Int. 2014; 86: 162–167. doi: 10.1038/ki.2013.460.Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O et al. Long-term risks for kidney donors. Kidney Int. 2014; 86: 162–167. doi: 10.1038/ki.2013.460.Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ et al. CRIB-Donor Study Investigators. Cardiovascular effects of unilateral nephrectomy in living kidney donors. Hypertension. 2016; 67: 368–377. doi: 10.1161/HYPERTENSIONAHA.115.06608.Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ et al. CRIB-Donor Study Investigators. Cardiovascular effects of unilateral nephrectomy in living kidney donors. Hypertension. 2016; 67: 368–377. doi: 10.1161/HYPERTENSIONAHA.115.06608.Paoletti E, Bellino D, Signori A, Pieracci L, Marsano L, Russo R et al. Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study. Nephrol Dial Transplant. 2016; 31: 1168–1174. doi: 10.1093/ndt/gfv354.Paoletti E, Bellino D, Signori A, Pieracci L, Marsano L, Russo R et al. Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study. Nephrol Dial Transplant. 2016; 31: 1168–1174. doi: 10.1093/ndt/gfv354.Шевченко ОП, Улыбышева АА, Гичкун ОЕ, Можейко НП, Стаханова ЕА, Кван ВС, Шевченко АО. Га лектин-3 при отторжении и фиброзе трансплантированного сердца. Вестник трансплантологии и искусственных органов. 2019; 21 (3): 62–68. doi: 10.15825/1995-1191-2019-3-62-68.Shevchenko OP, Ulybysheva AA, Gichkun OE, Mozheiko NP, Stakhanova EA, Kvan VS, Shevchenko AO. Galectin-3 in heart transplant rejection and fibrosis. Russian Journal of Transplantology and Artificial Organs. 2019; 21 (3): 62–68. doi: 10.15825/1995-1191-2019-3-62-68.Tarjus A, Martínez-Martínez E, Amador C, Latouche C, El Moghrabi S, Berger T et al. Neutrophil gelatinaseassociated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids. Hypertension. 2015; 66: 158–166. doi: 10.1161/HYPERTENSIONAHA.115.05431.Tarjus A, Martínez-Martínez E, Amador C, Latouche C, El Moghrabi S, Berger T et al. Neutrophil gelatinaseassociated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids. Hypertension. 2015; 66: 158–166. doi: 10.1161/HYPERTENSIONAHA.115.05431.Martínez-Martínez E, Cachofeiro V, Rousseau E, Álvarez V, Calvier L, Fernández-Celis A et al. Interleukin-33/ ST2 system attenuates aldosterone-induced adipogenesis and inflammation. Mol Cell Endocrinol. 2015; 411: 20–27. doi: 10.1016/j.mce.2015.04.007.Martínez-Martínez E, Cachofeiro V, Rousseau E, Álvarez V, Calvier L, Fernández-Celis A et al. Interleukin-33/ ST2 system attenuates aldosterone-induced adipogenesis and inflammation. Mol Cell Endocrinol. 2015; 411: 20–27. doi: 10.1016/j.mce.2015.04.007.López-Andrés N, Rousseau A, Akhtar R, Calvier L, Iñigo C, Labat C et al. Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension. 2012; 60: 563–573. doi: 10.1161/HYPERTENSIONAHA.112.194407.López-Andrés N, Rousseau A, Akhtar R, Calvier L, Iñigo C, Labat C et al. Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension. 2012; 60: 563–573. doi: 10.1161/HYPERTENSIONAHA.112.194407.Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Muñoz A et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019; 12: 153–166. doi: 10.2147/IJNRD.S167477.Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Muñoz A et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019; 12: 153–166. doi: 10.2147/IJNRD.S167477.Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017; 13 (4): 241–257. doi: 10.1038/nrneph.2017.2.Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017; 13 (4): 241–257. doi: 10.1038/nrneph.2017.2.Ostermann M, Cerda J. The burden of acute kidney injury and related financial issues. In: Ding X, Rosner MH, Ronco C, eds. Acute Kidney Injury – Basic Research and Clinical Practice. Basel, Switzerland: Contrib Nephrol, Karger; 2018: 100–112.Ostermann M, Cerda J. The burden of acute kidney injury and related financial issues. In: Ding X, Rosner MH, Ronco C, eds. Acute Kidney Injury – Basic Research and Clinical Practice. Basel, Switzerland: Contrib Nephrol, Karger; 2018: 100–112.Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018; 14 (10): 607–625. doi: 10.1038/s41581-018-0052-0.Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018; 14 (10): 607–625. doi: 10.1038/s41581-018-0052-0.Moore BJ (IBM Watson Health), Torio CM (AHRQ). Acute Renal Failure Hospitalizations, 2005–2014. HCUP Statistical Brief #231. Rockville, MD: Agency for Healthcare Research and Quality; 2017. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb231-Acute-RenalFailure-Hospitalizations.jsp.Moore BJ (IBM Watson Health), Torio CM (AHRQ). Acute Renal Failure Hospitalizations, 2005–2014. HCUP Statistical Brief #231. Rockville, MD: Agency for Healthcare Research and Quality; 2017. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb231-Acute-RenalFailure-Hospitalizations.jsp.Kerr M, Bedford M, Matthews B, O’Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014; 29 (7): 1362–1368. doi: 10.1093/ndt/gfu016.Kerr M, Bedford M, Matthews B, O’Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014; 29 (7): 1362–1368. doi: 10.1093/ndt/gfu016.Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006; 81: 542–546.Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006; 81: 542–546.Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31. doi: 10.1186/cc5713.Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31. doi: 10.1186/cc5713.Kidney disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl. 2012; 2: 1–138. doi: 10.1038/kisup.2012.1.Kidney disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl. 2012; 2: 1–138. doi: 10.1038/kisup.2012.1.Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015; 26 (9): 2231–2238.Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015; 26 (9): 2231–2238.Salgado G, Landa M, Masevicius D, Gianassi S, SanRomán JE, Silva L et al. Acute renal failure according to the RIFLE and AKIN criteria: a multicenter study. Med Intensiva. 2014; 38 (5): 271–277. doi: 10.1016/j.medin.2013.04.007.Salgado G, Landa M, Masevicius D, Gianassi S, SanRomán JE, Silva L et al. Acute renal failure according to the RIFLE and AKIN criteria: a multicenter study. Med Intensiva. 2014; 38 (5): 271–277. doi: 10.1016/j.medin.2013.04.007.Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X. Beijing Acute Kidney Injury Trial (BAKIT) workgroup. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Critical Care. 2014; 18: R144. doi: 10.1186/cc13977.Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X. Beijing Acute Kidney Injury Trial (BAKIT) workgroup. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Critical Care. 2014; 18: R144. doi: 10.1186/cc13977.Yong Z, Pei X, Zhu B, Yuan H, Zhao W. Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials. Sci Rep. 2017; 7: 41012. doi: 10.1038/srep41012.Yong Z, Pei X, Zhu B, Yuan H, Zhao W. Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials. Sci Rep. 2017; 7: 41012. doi: 10.1038/srep41012.Шевченко ОП, Улыбышева АА, Можейко НП, Гичкун ОЕ, Стаханова ЕА, Васильева ВП, Шевченко АО. Диагностическая значимость галектина-3 при патологии миокарда трансплантированного сердца. Вестник трансплантологии и искусственных органов. 2020; 22 (1): 8–15. doi: 10.15825/1995-1191-2020-1-8-15.Shevchenko OP, Ulybysheva AA, Mozheiko NP, Gichkun OE, Stakhanova EA, Vasilieva VP, Shevchenko AO. Diagnostic value of galectin-3 in heart transplant recipients with myocardial complications. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (1): 8–15. doi: 10.15825/1995-1191-2020-1-8-15.Schulz C-A, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM et al. High level of fasting plasma proenkephalin-a predicts deterioration of kidney function and incidence of CKD. J Am Soc Nephrol. 2017; 28: 291–303. doi: 10.1681/ASN.2015101177.Schulz C-A, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM et al. High level of fasting plasma proenkephalin-a predicts deterioration of kidney function and incidence of CKD. J Am Soc Nephrol. 2017; 28: 291–303. doi: 10.1681/ASN.2015101177.Lin X, Yuan J, Zhao Y, Zha Y. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. J Nephrol. 2015; 28: 7–16. doi: 10.1007/s40620-014-0113-9.Lin X, Yuan J, Zhao Y, Zha Y. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. J Nephrol. 2015; 28: 7–16. doi: 10.1007/s40620-014-0113-9.Hošková L, Franekova J, Málek I, Kautzner J, Szárszoi O, Jabor A et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. Ann Transplant. 2016; 21: 329– 245. doi: 10.12659/aot.896700.Hošková L, Franekova J, Málek I, Kautzner J, Szárszoi O, Jabor A et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. Ann Transplant. 2016; 21: 329– 245. doi: 10.12659/aot.896700.Великий ДА, Гичкун ОЕ, Шевченко ОП. МикроРНК у реципиентов сердечного трансплантата. Вестник трансплантологии и искусственных органов. 2017; 19 (2): 126–132. https://doi.org/10.15825/1995-1191-2017-2-126-132.Velikiy DA, Gichkun OE, Shevchenko OP. MicroRNAs in heart transplant recipients. Russian Journal of Transplantology and Artificial Organs. 2017; 19 (2): 126–132. (In Russ.) https://doi.org/10.15825/1995-1191-2017-2-126-132.Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB. et. al. Urinary L-FABP predicts poor out comes in critically ill patients with early acute kidney injury. Kidney Int. 2015; 87: 640–648. doi: 10.1038/ki.2014.301.Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB. et. al. Urinary L-FABP predicts poor out comes in critically ill patients with early acute kidney injury. Kidney Int. 2015; 87: 640–648. doi: 10.1038/ki.2014.301.Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transpl. 2009; 24: 3265–3268. doi: 10.1093/ndt/gfp010.Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transpl. 2009; 24: 3265–3268. doi: 10.1093/ndt/gfp010.Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17: R25. doi: 10.1186/cc12503.Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17: R25. doi: 10.1186/cc12503.Teo SH, Zoltán, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017; 31 (3): 331–344. doi: 10.1016/j.bpa.2017.10.003.Teo SH, Zoltán, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017; 31 (3): 331–344. doi: 10.1016/j.bpa.2017.10.003.Pickering JW, Endre ZH. Bench to bedside: the next steps for biomarkers in acute kidney injury. Am J Physiol – Ren Physiol. 2016; 311: F717–721. doi: 10.1152/ajprenal.00268.2016.Pickering JW, Endre ZH. Bench to bedside: the next steps for biomarkers in acute kidney injury. Am J Physiol – Ren Physiol. 2016; 311: F717–721. doi: 10.1152/ajprenal.00268.2016.Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, Joannidis M. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018; 44: 323–336. doi: 10.1007/s00134- 018-5126-8.Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, Joannidis M. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018; 44: 323–336. doi: 10.1007/s00134- 018-5126-8.Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report – 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019; 38 (10): 1056–1066. doi: 10.1016/j.healun.2019.08.004.Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report – 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019; 38 (10): 1056–1066. doi: 10.1016/j.healun.2019.08.004.Thongprayoon C, Lertjitbanjong P, Hansrivijit P, Crisafio A, Mao M, Watthanasuntorn K et al. Acute Kidney Injury in Patients Undergoing Cardiac Transplantation: A Meta-Analysis. Medicines (Basel). 2019; 6 (4): 108. doi: 10.3390/medicines6040108.Thongprayoon C, Lertjitbanjong P, Hansrivijit P, Crisafio A, Mao M, Watthanasuntorn K et al. Acute Kidney Injury in Patients Undergoing Cardiac Transplantation: A Meta-Analysis. Medicines (Basel). 2019; 6 (4): 108. doi: 10.3390/medicines6040108.Гольц АМ, Захаревич ВМ. Ретрансплантация сердца. Трансплантология: итоги и перспективы. Под ред. С.В. Готье. М.–Тверь: Триада, 2019: 271–290.Goltz AM, Zakharevich VM. Retransplantatsiya serdtsa. Transplantologiya: itogi i perspektivy. Pod red. S.V. Gautier. M.–Tver’: Triada, 2019: 271–290.Zijlstra LE, Constantinescu AA, Manintveld O, Birim O, Hesselink DA, van Thiel R et al. Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience. Transpl Int. 2015; 28: 962–971. doi: 10.1111/tri.12503.Zijlstra LE, Constantinescu AA, Manintveld O, Birim O, Hesselink DA, van Thiel R et al. Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience. Transpl Int. 2015; 28: 962–971. doi: 10.1111/tri.12503.Tjahjono R, Connellan M, Granger E. Predictors of Acute Kidney Injury in Cardiac Transplantation. Transplant Proc. 2016; 48 (1): 167–172. doi: 10.1016/j.transproceed.2015.12.006.Tjahjono R, Connellan M, Granger E. Predictors of Acute Kidney Injury in Cardiac Transplantation. Transplant Proc. 2016; 48 (1): 167–172. doi: 10.1016/j.transproceed.2015.12.006.García-Gigorro R, Renes-Carreño E, Peiretti MAC, López PA, Vela JLP, Rodríguez JG et al. Incidence, Risk Factors and Outcomes of Early Acute Kidney Injury After Heart Transplantation: An 18-year Experience. Transplantation. 2018; 102 (11): 1901–1908. doi: 10.1097/TP.0000000000002293.García-Gigorro R, Renes-Carreño E, Peiretti MAC, López PA, Vela JLP, Rodríguez JG et al. Incidence, Risk Factors and Outcomes of Early Acute Kidney Injury After Heart Transplantation: An 18-year Experience. Transplantation. 2018; 102 (11): 1901–1908. doi: 10.1097/TP.0000000000002293.Wang T-J, Lin C-H, Wei H-J, Wu M-J. Long-Term Outcomes and Risk Factors of Renal Failure Requiring Dialysis after Heart Transplantation: A Nationwide Cohort Study. J Clin Med. 2020, 9 (8), 2455; https://doi.org/10.3390/jcm9082455.Wang T-J, Lin C-H, Wei H-J, Wu M-J. Long-Term Outcomes and Risk Factors of Renal Failure Requiring Dialysis after Heart Transplantation: A Nationwide Cohort Study. J Clin Med. 2020, 9 (8), 2455; https://doi.org/10.3390/jcm9082455.Wang L, Wang T, Rushton SN, Parry G, Dark JH, Sheerin NS. The impact of severe acute kidney injury requiring renal replacement therapy on survival and renal function of heart transplant recipients – a UK cohort study. Transpl Int. 2020 Jun 16. doi: 10.1111/tri.13675.Wang L, Wang T, Rushton SN, Parry G, Dark JH, Sheerin NS. The impact of severe acute kidney injury requiring renal replacement therapy on survival and renal function of heart transplant recipients – a UK cohort study. Transpl Int. 2020 Jun 16. doi: 10.1111/tri.13675.Boyle JM, Moualla S, Arrigain S, Worley S, Bakri MH, Starling RC et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006; 48 (5): 787–796. doi: 10.1053/j.ajkd.2006.08.002.Boyle JM, Moualla S, Arrigain S, Worley S, Bakri MH, Starling RC et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006; 48 (5): 787–796. doi: 10.1053/j.ajkd.2006.08.002.Guven G, Brankovic M, Constantinescu AA, Brugts JJ, Hesselink DA. Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation. Intensive Care Med. 2018; 44: 588–597. doi: 10.1007/s00134-018-5159-z.Guven G, Brankovic M, Constantinescu AA, Brugts JJ, Hesselink DA. Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation. Intensive Care Med. 2018; 44: 588–597. doi: 10.1007/s00134-018-5159-z.Romeo FJ, Varela CF, Vulcano N, Pizarro R, Greloni G, Posatini R et al. Acute Kidney Injury After Cardiac Transplantation: Foe or Common Innocent Bystander? Transplant Proc. 2018; 50 (5): 1489–1495. doi: 10.1016/j.transproceed.2018.03.106.Romeo FJ, Varela CF, Vulcano N, Pizarro R, Greloni G, Posatini R et al. Acute Kidney Injury After Cardiac Transplantation: Foe or Common Innocent Bystander? Transplant Proc. 2018; 50 (5): 1489–1495. doi: 10.1016/j.transproceed.2018.03.106.

The authors declare that there are no conflicts of interest present.